Interesting to see that Synergetics USA ophthalmology business up 16% Q1 Fiscal 2009. Of note domestic ophthalmology sales (higher vitreoretinal instrument sales and disposables) were up 7% only while international was up 34%.
Archive | All RSS feed for this section
Dan Meuser – From Pride President To Full Time Politician
Dan Meuser, until recently President at Pride Mobility, is now focusing his time 100% on state GOP politics. More at The Bulletin. Hopefully with his experience he can help bring better quality and cost effective healthcare to those that need it – especially the 40 million uninsured Americans.
Novartis Still On Track to Buy Majority In Alcon
Novartis Chief Executive Daniel Vasella confirmed that Novartis is still on track to buy a majority share in Alcon in a report December 5, 2008 in Switzerland
Invacare Dedicates Site To Paralympics
Invacare Dedicates Site To Paralympics.
Bruno Cocheteux Joins Sibaya Lifescience – Heads Up New Pharmaceutical And Medical Device Operations And R&D Practice
Press Release: Sibaya LifeScience is pleased to announce that Bruno Cocheteux has joined the firm as a managing partner heading up the Operations and R&D practice. Bruno comes to Sibaya from a Fortune 500 pharmaceutical and medical device multinational where he was a world wide operations leader. In this role Bruno performed a variety of [...]
Carl Zeiss Meditec, Medical Technology for Ophthalmology
Carl Zeiss Meditec, medical technology for ophthalmology and othe specialties – Speeds up growth and changes management structure. .
Ophthalmic Pharmaceuticals Enjoy Good Potential in South Africa – MarketWatch
Ophthalmic Pharmaceuticals Good Growth Potential South Africa – MarketWatch.
Alcon second-quarter profit rises 26 pct
Novartis picks up initial 26% equity in ophthalmics manufacturer Alcon from Nestlé. Alcon second-quarter profit rises 26 pct.
Follow @sibaya_com on Twitter
